Anderson School

ACELYRIN, INC. Appoints Patricia Turney as Chief Technical Operations Officer

Retrieved on: 
Monday, November 6, 2023
SLRN, Sigma, External, Engineering, Strategic planning, York Region District School Board, MD, CMC, Federal Aviation Administration, Doctor of Philosophy, HBA, Senior, Growth, University, Business administration, Amgen, LOS, Chairperson, Benchmarking, Anderson School, Hispanics in the United States Naval Academy, United States Department of the Navy, INC, Patient, Management, Science, Mathematics

LOS ANGELES, Nov. 06, 2023 (GLOBE NEWSWIRE) -- ACELYRIN, INC. (Nasdaq: SLRN), a late-stage clinical biopharma company focused on accelerating the development and delivery of transformative medicines in immunology, today announced the appointment of Patricia Turney as Chief Technical Operations Officer. Reporting to Founder and CEO Shao-Lee Lin, MD, PhD, Ms. Turney will be responsible for overseeing technical operations, CMC regulatory, corporate quality and facilities, and will join the company’s Senior Leadership Team.

Key Points: 
  • (Nasdaq: SLRN), a late-stage clinical biopharma company focused on accelerating the development and delivery of transformative medicines in immunology, today announced the appointment of Patricia Turney as Chief Technical Operations Officer.
  • Reporting to Founder and CEO Shao-Lee Lin, MD, PhD, Ms. Turney will be responsible for overseeing technical operations, CMC regulatory, corporate quality and facilities, and will join the company’s Senior Leadership Team.
  • “I am delighted to welcome Patricia to the ACELYRIN leadership team as we continue to advance our portfolio and grow our manufacturing capabilities and capacity,” said Dr. Lin.
  • Earlier in her career at Amgen, she also led R&D strategic operations initiatives for portfolio analysis, benchmarking, training, lean six sigma, and strategic planning.

ReNAgade Therapeutics Appoints Laurie Stelzer as Chief Financial Officer

Retrieved on: 
Tuesday, September 12, 2023
Health, Genetics, Research, Pharmaceutical, Science, Biotechnology, Tissue, Treasury, Amgen, University, Mirati Therapeutics, Renegade, Anderson School, Cell, RNA, UCLA Anderson School of Management, Acquisition, Arizona State University, CFO, Growth, Therapy, Accounting, Pfizer, Management

ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced the appointment of Laurie Stelzer as Chief Financial Officer.

Key Points: 
  • ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced the appointment of Laurie Stelzer as Chief Financial Officer.
  • Ms. Stelzer most recently served as Chief Financial Officer of Mirati Therapeutics and brings over 25 years of experience to further strengthen ReNAgade’s leadership team.
  • “Laurie is an accomplished leader with extensive experience across the pharmaceutical and biotech industries, whose work has spanned corporate finance and strategy, business development, and helping to build key capabilities necessary to create long-term value for stakeholders,” said Amit D. Munshi, Chief Executive Officer of ReNAgade.
  • “Having worked with Laurie for over 20 years, I am very excited to welcome her to the ReNAgade leadership team as our first Chief Financial Officer as we continue to advance our science and growth of the company.”
    “In advancing its industry leading platform, ReNAgade is poised to bring RNA medicines to previously inaccessible tissues and cells in the body,” said Ms. Stelzer.

Lev Peker Appointed to Faraday Future’s Board of Directors

Retrieved on: 
Friday, August 4, 2023
Software, EV, Electric Vehicles, Internet, Luxury, Alternative Energy, Energy, General Automotive, Technology, Automotive, Retail, Automotive Manufacturing, Manufacturing, Shift, BS, UCLA Anderson School of Management, Selection Committee, Audit committee, Anderson School, Business, MBA, Multimedia, Certified Public Accountant, Shift Technologies, EBITDA, CPA, Adorama, UCLA, Letter, Corporate title, Sears Holdings, FF, Accounting, Compensated emancipation, Management

Faraday Future Intelligent Electric Inc. (Nasdaq: FFIE) (“FF,” “Faraday Future,” or “Company”), a California-based global shared intelligent electric mobility ecosystem company, announced today that the Board of Directors of the Company (the "Board”) unanimously appointed Lev Peker as a member of the Board and as a member and the Chair of the Audit Committee of the Board.

Key Points: 
  • Faraday Future Intelligent Electric Inc. (Nasdaq: FFIE) (“FF,” “Faraday Future,” or “Company”), a California-based global shared intelligent electric mobility ecosystem company, announced today that the Board of Directors of the Company (the "Board”) unanimously appointed Lev Peker as a member of the Board and as a member and the Chair of the Audit Committee of the Board.
  • View the full release here: https://www.businesswire.com/news/home/20230804447859/en/
    Lev Peker Appointed to Faraday Future’s Board of Directors (Photo: Business Wire)
    Mr. Peker is an automotive and retail experienced C-Suite executive who has served in the CEO role, as well as on the board of directors at various public and private organizations.
  • Mr. Peker is currently the CEO of PartsiD, a leading digital commerce platform for the automotive aftermarket.
  • Prior to that, Mr. Peker was the CEO of CarLotz, a nationwide used car consignment retailer (which recently merged with Shift Technologies).

Jeffrey Davis Joining Eastdil Secured as Managing Director

Retrieved on: 
Wednesday, July 19, 2023
Professional Services, Commercial Building & Real Estate, Lodging, Finance, Construction & Property, Travel, Banking, Resorts World, Bachelor of Science in Hospitality & Catering Management, Senior, Capital market, Fairmont Copley Plaza, JLL, Anderson School, Salomon Brothers, L.L.C, Mandarin, MBA, Strategic planning, York Region District School Board, Standard, Cornell University, Boca Raton Resort & Club, Morgans Hotel Group, UCLA, Management, Hotel

(“Eastdil Secured” or the “firm”), the global real estate investment bank, today announced that Jeffrey Davis will be joining Eastdil Secured as Managing Director.

Key Points: 
  • (“Eastdil Secured” or the “firm”), the global real estate investment bank, today announced that Jeffrey Davis will be joining Eastdil Secured as Managing Director.
  • “Jeff is a deeply talented and trusted advisor, and we are pleased to welcome him to the firm,” said Roy Hilton March, CEO of Eastdil Secured.
  • He joins Eastdil Secured following an accomplished 18-year tenure at JLL, where he served as Senior Managing Director and head of the US Hotels Investment Sales Capital Markets team, responsible for overseeing all full-service hotel investment sales in the Americas.
  • Prior to joining JLL, Mr. Davis served as vice president of asset management and business development for Ian Schrager at Morgans Hotel Group.

Susan M. Love, MD, MBA, Chief Visionary Officer and "Founding Mother" of Breast Cancer Advocacy and Research Dies

Retrieved on: 
Monday, July 3, 2023
President Clinton, Volunteering, Love, Executive, Surgeon, Fordham University, University, Army, Brigham and Women's Faulkner Hospital, Parent, State university system, Radiology, National Breast Cancer Coalition, Anderson School, Marriage, Woman, MBA, Research, History, Alpha Omega Alpha, Young Survival Coalition, Movement, HRT, NBCC, SUNY Downstate Medical Center, Beth Israel Hospital, International Symposium on Endovascular Therapy, MD, Breast cancer, The New York Times, Patient, Notre Dame, Revlon, Breast, Supreme court, School Sisters of Notre Dame, LOS, AI, Oncology, UCLA, State University of New York Upstate Medical University, Leukemia, Mammography, NIH, Hormone replacement therapy, Birth control, Medical device

LOS ANGELES, July 3, 2023 /PRNewswire/ -- Susan M. Love, MD, MBA, who led Dr. Susan Love Foundation for Breast Cancer Research since 1995, steering the Foundation through its innovative and life-changing research and advocacy programs, has died. She was 75.

Key Points: 
  • She was an early advocate of cancer surgery that conserves as much breast tissue as possible.
  • A founder of the breast cancer advocacy movement in the early 1990's, she helped organize the National Breast Cancer Coalition (NBCC) .
  • As Founder and Chief Visionary Officer of the Dr. Susan Love Foundation for Breast Cancer Research, Dr. Love built and oversaw an active research program centered on the cause and prevention of breast cancer.
  • The Love Research Army, which she launched in 2008, creatively accelerated cancer research by partnering volunteers and scientists for clinical trials and cancer research.

Strive Health Names Eric Van Horn as Advisor

Retrieved on: 
Thursday, June 15, 2023
Managed Care, Diabetes, Health Technology, Health, University of Southern California, University of California, San Diego, CMS, University, Senior, Centers for Medicare & Medicaid Services, Anderson School, Multimedia, Pharmacy, UCLA Anderson School of Management, Sale, Decision Sciences, Medicare, Public health, Community, Harvard T.H. Chan School of Public Health, Patient, School, Management

Strive Health , the national leader in value-based kidney care, announced today that it named veteran healthcare leader Eric Van Horn as Advisor to the company’s executive team.

Key Points: 
  • Strive Health , the national leader in value-based kidney care, announced today that it named veteran healthcare leader Eric Van Horn as Advisor to the company’s executive team.
  • Van Horn will work closely with Strive co-founder and CEO Chris Riopelle as well as the company’s operations, finance and growth teams to help propel Strive forward.
  • Van Horn has been a professor at the University of California, Irvine, and University of Southern California in the School of Public Health for the past 12 years.
  • “I’m excited to help Chris and the leadership team build on the impressive growth Strive has already achieved,” Van Horn said.

East West Bank Appoints Dr. Jason Hsu of Rayliant Global Advisors as Chief Economist

Retrieved on: 
Tuesday, May 23, 2023
Banking, Asset Management, Professional Services, Finance, Uncertainty, Partnership, University, Anderson School, Multimedia, UCLA Anderson School of Management, Kyoto University, Tsinghua University, National Chengchi University, University of California, Los Angeles, Bank, UCLA, Robert D. Arnott, National Advisory Committee on Institutional Quality and Integrity, Data science, Cryptocurrency

East West Bancorp, Inc. ("East West" or the "Company") (Nasdaq: EWBC), parent company of East West Bank , today announced the appointment of Dr. Jason Hsu , founder and Chief Investment Officer of Rayliant Global Advisors (“Rayliant”), as the Chief Economist for East West Bank.

Key Points: 
  • East West Bancorp, Inc. ("East West" or the "Company") (Nasdaq: EWBC), parent company of East West Bank , today announced the appointment of Dr. Jason Hsu , founder and Chief Investment Officer of Rayliant Global Advisors (“Rayliant”), as the Chief Economist for East West Bank.
  • View the full release here: https://www.businesswire.com/news/home/20230523006078/en/
    Rayliant founder and new East West Bank Chief Economist Dr. Jason Hsu (Photo: Business Wire)
    “Dr.
  • Hsu is a preeminent leader in the fields of finance and investment management, and we are delighted to welcome him as the Chief Economist of East West Bank,” stated Dominic Ng, Chairman and Chief Executive Officer of East West Bancorp.
  • “East West Bank and Rayliant were both founded on a shared mission of serving as the bridge between the East and West.

WellBiz Brands Inc. Appoints Ankin Laysha as COO

Retrieved on: 
Tuesday, May 23, 2023
University, London, Anderson School, McKinsey & Company, UCLA Anderson School of Management, Beauty, Laysha, Empathy, Fitness, Radiant, London School of Business and Finance, Retail, Management, Economics

DENVER, May 23, 2023 /PRNewswire/ -- WellBiz Brands Inc., the pre-eminent beauty and wellness franchise platform, has named Ankin Laysha as the company's chief operating officer. In her new role, Laysha will help the company implement a new operations support model for franchisees.

Key Points: 
  • DENVER, May 23, 2023 /PRNewswire/ -- WellBiz Brands Inc. , the pre-eminent beauty and wellness franchise platform, has named Ankin Laysha as the company's chief operating officer.
  • WellBiz Brands Inc. has named Ankin Laysha as the company's chief operating officer.
  • Laysha brings broad experience in strategy, innovation and franchising in the beauty, wellness and fitness sectors to her new role.
  • WellBiz Brands CEO Jeremy Morgan said, "Ankin brings impressive energy and experience to WellBiz Brands' operations team at a critical time.

Consonance Capital Partners Adds Eric Van Horn to Operating Council

Retrieved on: 
Monday, May 15, 2023
General Health, Finance, Banking, Health, Professional Services, University of California, San Diego, Partnership, CMS, University, Senior, Centers for Medicare & Medicaid Services, University of California, Irvine Medical Center, Partner, Anderson School, Pharmacy, UCLA Anderson School of Management, National Operations Council, Sale, Decision Sciences, Medicare, CareMore, Public health, Community, Harvard T.H. Chan School of Public Health, Physician, Risk, School, Senior Advisor to the President of the United States, Growth, Entrepreneurship, Center for Medicare and Medicaid Innovation, Mitchell J. Blutt, Economics, Management

Consonance Capital Partners, a leading U.S.-based healthcare private equity firm, today announced that it has added health care leader Eric Van Horn to its Operating Council.

Key Points: 
  • Consonance Capital Partners, a leading U.S.-based healthcare private equity firm, today announced that it has added health care leader Eric Van Horn to its Operating Council.
  • Consonance Capital Partners’ Operating Council and Senior Advisory Board members work closely with the firm’s investment professionals, bringing valuable market insights, helping to source and diligence deals, and advising portfolio company management teams and serving on their boards of directors.
  • “Eric has unique and differentiated experience in advanced care models that help bring high quality care and superior outcomes to the medically frail population which is core to what we work to do at Consonance Capital Partners.
  • Eric joins a deep bench of senior healthcare executives and experts at Consonance Capital Partners.

Kiavi Appoints Seasoned Finance Leader Alex Urmersbach as Chief Financial Officer

Retrieved on: 
Thursday, April 13, 2023
Capital market, Hohenheim, Business operations, Anderson School, Urmersbach, MBA, UCLA Anderson School of Management, Prospect Mortgage, Bank of America, SAN, Homebridge Financial Services, Growth, Ageing, Bank, UCLA, Financial management, Real estate, Accounting

SAN FRANCISCO, April 13, 2023 /PRNewswire/ -- Kiavi, a leading provider of financing to real estate investors, today announced the appointment of Alex Urmersbach as Chief Financial Officer. In this role, Urmersbach will lead Kiavi's financial strategy and operations, including the company's Finance, Accounting, Capital Markets, and Business Operations functions. Urmersbach's deep experience in the lending and mortgage sectors will further bolster Kiavi's position as a reliable, trusted financing partner to real estate investors.

Key Points: 
  • SAN FRANCISCO, April 13, 2023 /PRNewswire/ -- Kiavi , a leading provider of financing to real estate investors, today announced the appointment of Alex Urmersbach as Chief Financial Officer.
  • In this role, Urmersbach will lead Kiavi's financial strategy and operations, including the company's Finance, Accounting, Capital Markets, and Business Operations functions.
  • Urmersbach brings more than 20 years of experience in financial management, driving growth, and operating scale to his new role.
  • Prior to joining Kiavi, he held Chief Financial Officer positions at private lender Athas Capital Group, global business process outsourcer Teleperformance, and mortgage lender Panorama Mortgage Group.